Strategic advice to leverage new technologies

For the last decade I have been asked, "What is the ROI for collaboration?" I have come to several conclusions about this: one, that it is the wrong question to ask (and is a trap in itself) and two, everyone wants collaboration, but no one seems willing to pay fo

Mobility is now one of the top strategic priorities for organizations. In fact, supporting mobility is seen as so important that some organizations are offering employees the option of using their own personal devices.

The Cutter IT Journal from August 2011 asks, "Devops: A Software Revolution in the Making?" (Vol. 24, No.

Last month I began an Advisor series that I am unofficially calling the "Scrum Ain't Enough" series (see "Agile

How does the explosion of social media and the blogosphere relate to your company? Are customers using Twitter and Facebook to talk about their experiences with your products or services? How do global geopolitical events impact your business?

Consider this Advisor a very pragmatic recommendation to the software development manager/director/VP. I have a feeling that the opinion I express here might get me in hot water, but what would life be like without some risk?

Over the last two decades, medical science has made significant progress in understanding the molecular mechanisms involved in the progression of cancer, and this progress has been accompanied by the development of new and more effective treatments. Yet the way in which cancer care is delivered and coordinated has by and large remained the same. Once diagnosed with cancer, most patients receive their care in a linear fashion.

I was recently asked by a client to evaluate a product in terms of scalability. The client had invested in a custom case management system that had 100 users and wanted to know whether the current architecture would support scaling to 3,000 users.